Lagania, Florentina C.
HRN: 22-69-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2023
CEFTRIAXONE 1G (VIAL)
03/01/2023
03/08/2023
IV
2gms
Od
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes